Solvay Reports Third-Quarter Profits Down; Evaluates Options for Reinvestment of Pharma Proceeds

08:29 AM | October 29, 2009 | Natasha Alperowicz

Solvay reported a 2% decrease in third quarter recurring earnings before interest and taxes (Rebit) at €285 million ($424 million) on 10% lower sales of €2.24 billion, citing difficult market...